Richard A. Colvin
2022
In 2022, Richard A. Colvin earned a total compensation of $1.4M as Chief Medical Officer at bluebird bio.
Compensation breakdown
| Non-Equity Incentive Plan | $216,000 |
|---|---|
| Option Awards | $374,297 |
| Salary | $467,639 |
| Stock Awards | $294,240 |
| Other | $12,600 |
| Total | $1,364,776 |
Colvin received $467.6K in salary, accounting for 34% of the total pay in 2022.
Colvin also received $216K in non-equity incentive plan, $374.3K in option awards, $294.2K in stock awards and $12.6K in other compensation.
Rankings
In 2022, Richard A. Colvin's compensation ranked 2,424th out of 5,736 executives tracked by ExecPay. In other words, Colvin earned more than 57.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,424 out of 5,736 | 58th |
Division Manufacturing | 1,330 out of 3,125 | 57th |
Major group Chemicals And Allied Products | 599 out of 1,416 | 58th |
Industry group Drugs | 553 out of 1,317 | 58th |
Industry Biological Products, Except Diagnostic Substances | 136 out of 291 | 53rd |
Source: SEC filing on April 28, 2023.
Colvin's colleagues
We found three more compensation records of executives who worked with Richard A. Colvin at bluebird bio in 2022.